APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $185,158,000 | -5.3% | 2,929,708 | -35.7% | 1.91% | -1.4% |
| Q1 2021 | $195,585,000 | -32.0% | 4,558,029 | -9.4% | 1.93% | -15.5% |
| Q4 2020 | $287,618,000 | +89.6% | 5,028,289 | 0.0% | 2.29% | +99.0% |
| Q3 2020 | $151,703,000 | -7.6% | 5,028,289 | 0.0% | 1.15% | -23.5% |
| Q2 2020 | $164,224,000 | +21.9% | 5,028,289 | 0.0% | 1.50% | -17.3% |
| Q1 2020 | $134,708,000 | -6.0% | 5,028,289 | +7.5% | 1.82% | +1.7% |
| Q4 2019 | $143,249,000 | +27.1% | 4,678,289 | 0.0% | 1.78% | +15.2% |
| Q3 2019 | $112,700,000 | +72.4% | 4,678,289 | +81.3% | 1.55% | +6.0% |
| Q2 2019 | $65,370,000 | +29.9% | 2,579,708 | 0.0% | 1.46% | +4.4% |
| Q1 2019 | $50,304,000 | +71.0% | 2,579,708 | +15.7% | 1.40% | +14.8% |
| Q4 2018 | $29,410,000 | – | 2,229,708 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |